Phase Ib/II trial of NC-6004 (nanoparticle cisplatin) plus gemcitabine (G) in pts with advanced solid tumors

被引：1
|
作者：
Subbiah, V. [1 ]
Combest, A. [2 ]
Griley-Olsen, J. [3 ]
Sharma, N. [4 ]
Andrews, E. [5 ]
Bobe, I. [6 ]
Balkissoon, J. [7 ]
Camp, A. [8 ]
Masada, A. [9 ]
Reitsma, D. [10 ]
Bazhenova, L. [11 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Invest Canc Therapeut, Houston, TX 77030 USA
[2] PPD, Global Prod Dev, Wilmington, NC USA
[3] Univ N Carolina, Lineberger Comprehens Canc Ctr, Hematol & Oncol, Chapel Hill, NC USA
[4] UH Case Med Ctr, Hematol & Oncol, Cleveland, OH USA
[5] PPD, GPD, Raleigh, NC USA
[6] NanoCarrier, Res, Danville, VA USA
[7] PPD, GPD, San Francisco, CA USA
[8] PPD, Biostat, Austin, TX USA
[9] NanoCarrier, Res & Dev, Tokyo, Japan
[10] PPD, Global Prod Dev, Rockville, MD USA
[11] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw368.41
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
398P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Binimetinib plus Gemcitabine and Cisplatin Phase I/II Trial in Patients with Advanced Biliary Cancers
    Lowery, Maeve A.
    Bradley, Mikaela
    Chou, Joanne F.
    Capanu, Marinela
    Gerst, Scott
    Harding, James J.
    El Dika, Imane
    Berger, Michael
    Zehir, Ahmet
    Ptashkin, Ryan
    Wong, Philip
    Rasalan-Ho, Teresa
    Yu, Kenneth H.
    Cercek, Andrea
    Morgono, Ezra
    Salehi, Erica
    Valentino, Emily
    Hollywood, Ellen
    O'Reilly, Eileen M.
    Abou-Alfa, Ghassan K.
    CLINICAL CANCER RESEARCH, 2019, 25 (03) : 937 - 945
  • [22] A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab-Paclitaxel and Gemcitabine in Advanced Solid Tumors
    Beatty, Gregory L.
    Shahda, Safi
    Beck, Thaddeus
    Uppal, Nikhil
    Cohen, Steven J.
    Donehower, Ross
    Gabayan, Afshin Eli
    Assad, Albert
    Switzky, Julie
    Zhen, Huiling
    Von Hoff, Daniel D.
    ONCOLOGIST, 2019, 24 (01): : 14 - +
  • [23] Phase I trial of cabazitaxel plus cisplatin in patients with advanced solid tumors.
    Lockhart, Albert C.
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Lane, Alex R.
    Moseley, Jennifer L.
    Dedieu, Jean-Francois
    Stash, Diane
    Zhi, Xin
    Mazuir, Florent
    Mita, Alain C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [24] Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial
    不详
    LANCET ONCOLOGY, 2008, 9 (01): : 39 - 44
  • [25] Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors
    Schultheis, B.
    Kummer, G.
    Zeth, M.
    Brendel, E.
    Xia, C.
    Kornacker, M.
    Strumberg, D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (02) : 333 - 339
  • [26] A PHASE IB TRIAL OF ZIV-AFLIBERCEPT PLUS PEMBROLIZUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS
    Tyan, Kevin
    Rahma, Osama
    Giobbie-Hurder, Anita
    Brohl, Andrew
    Bedard, Philippe
    Renouf, Daniel
    Sharon, Elad
    Streicher, Howard
    Hathaway, Emma
    Cunningham, Rachel
    Manos, Michael
    Severgnini, Mariano
    Rodig, Scott
    Hodi, F. Stephen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A402 - A404
  • [27] Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors
    B. Schultheis
    G. Kummer
    M. Zeth
    E. Brendel
    C. Xia
    M. Kornacker
    D. Strumberg
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 333 - 339
  • [28] Phase I study of pemetrexed (P) plus gemcitabine (G) in advanced solid tumors (ST)
    Fury, M. G.
    Larkin, J.
    Gerst, S. R.
    Sabbatini, P.
    Konner, J.
    Orlando, M.
    Tai, D. F.
    Goss, T.
    Aghajanian, C.
    Hensley, M. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors
    Brian A. Costello
    Mitesh J. Borad
    Yingwei Qi
    George P. Kim
    Donald W. Northfelt
    Charles Erlichman
    Steven R. Alberts
    Investigational New Drugs, 2014, 32 : 710 - 716
  • [30] Pemetrexed/gemcitabine/cisplatin: Phase I trial in patients with solid tumors
    Bolling, C
    Lubbing, C
    Graefe, T
    Mack, S
    Von Scheel, J
    Muller-Hagen, S
    Blatter, J
    Depenbrock, H
    Ohnmacht, U
    Hanauske, AR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 218S - 218S
12345